Ergopeptine Mesylate

Images are for illustration purposes only;
actual packaging may vary.

Ergopeptine Mesylate is a potent active pharmaceutical ingredient commonly utilized in compounded formulations for its vasoconstrictive and dopaminergic properties. This ergot derivative is often employed in medical treatments that require modulation of vascular tone and neurotransmitter activity, making it a valuable component in addressing conditions related to vascular and neurological health.

Its efficacy in influencing dopamine receptors also positions Ergopeptine Mesylate as a critical agent in therapies aimed at managing symptoms associated with hormonal imbalances and certain neurological disorders. Healthcare professionals appreciate its versatility and targeted action, which can be tailored to meet specific patient needs through customized compounding solutions.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Ergopeptine Mesylate is a potent active pharmaceutical ingredient commonly utilized in compounded formulations for its therapeutic properties. As a derivative of ergot alkaloids, it exhibits a unique mechanism of action that primarily targets the dopaminergic and serotonergic receptors, making it effective in managing various medical conditions.

Its pharmacological profile is characterized by its ability to modulate neurotransmitter activity, which can be beneficial in treating disorders related to vascular and neurological systems. Ergopeptine Mesylate is often prescribed for its vasoconstrictive properties, which can aid in the management of migraines and other vascular headaches.

Additionally, its role in influencing prolactin levels makes it a valuable component in formulations aimed at addressing hyperprolactinemia. The compound's efficacy and safety profile have been well-documented, providing healthcare professionals with confidence in its use for tailored patient care.

When considering Ergopeptine Mesylate for therapeutic use, it is essential to evaluate patient-specific factors to optimize treatment outcomes. Its inclusion in compounded formulations allows for personalized dosing and delivery methods, enhancing patient adherence and satisfaction.

Formulas using

Ergopeptine Mesylate

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.